Glenmark's consolidated net profit declines by 31% in Q2

Glenmark Pharmaceuticals, the research-led global integrated pharmaceutical company, has suffered a setback during the second quarter ended September 2009 and its consolidated net profit declined sharply by 31.1 per cent to Rs 80.89 crore from Rs 117.36 crore in the corresponding period of last year. This is mainly on account of significant higher interest cost. Its consolidated net sales increased by 5.5 per cent to Rs 590.33 crore from Rs 559.72 crore. 

Comments

Post a Comment

Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Image
GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut    Vox Author of GOP Tax Plan Says Children's Health Insurance Program Is Held Up “Because We Don't Have Money ...    The Intercept Nevada wins short reprieve in child health care funds fight    Sacramento Bee Ben McAdams: Congress to Tiny Tim: 'No health insurance for you.'    Salt Lake Tribune Full coverage
Read more

Trump wants more mental health care; Alabama says it's trying

Image
Trump wants more mental health care; Alabama says it's trying    AL.com Budget undercuts Trump focus on mental health, school safety    Yahoo News Mental health awareness license plates offered by New York State DMV    Buffalo News Trump wants to 'tackle the difficult issue of mental health?' He should put his money where his mouth is.    Washington Post Full coverage
Read more